- Home
- Diabetology
- Real-World Management of Type 2 Diabetes with Linagliptin/Empagliflozin: A Patient-Centered Case Experience

1w3 min read
Medical Article
Introduction Type 2 diabetes mellitus (T2DM) is a progressive chronic condition that often requires combination therapy to achieve optimal glycemic control while minimizing the risk of complications (1). Beyond glucose lowering, modern treatment goals emphasize organ protection, especially cardiovascular and renal outcomes (1). Fixed-dose combinati

Real-World Management of Type 2 Diabetes with Linagliptin/Empagliflozin: A Patient-Centered Case Experience
Similar Content

Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes

Short-term Insulin Therapy for better Glycemic Control
14 Reached5 Comments6 Likes

Autoimmune Hepatitis in Girl with T1DM
1154 Reached2 Comments4 Likes

Risk Factors Associated Glycemia in LBW Infants
2793 Reached2 Comments1 Likes

Link between PCOS, Obesity and Diabetes
479 Reached2 Likes